Hemostemix Inc (OTCMKTS:HMTXF) Stock Falls After Announcing a New Appointment

It was a tough day in the markets for Hemostemix Inc (OTCMKTS:HMTXF) as the stock suffered from a selloff and went down by as much as 6%. The selloff in the stock was actually triggered by an announcement from the company with regards to the addition of Dr Renzo Cecere to the Scientific Advisory Board at Hemostemix.

Trading Data

On Wednesday, HMTXF stock slid 5.97% to $0.1489 with more than 1.12K shares, compared to its average volume of 6.16K shares. The stock moved within a range of $0.1489 – 0.1489 after opening trade at $0.1489.

Hemostemix Announces the Appointment of Dr. Renzo Cecere, MD, FRCSC to Its Scientific Advisory Board

While the reaction of investors to the news triggered the selloff, it may be a good idea to take a look at DrCecere’s credentials and then make your minds up about the merits of the appointment.

DrCecere is not only the Chief of Cardiac Surgery at McGill University but also the Director of the Mechanical Circulatory Support Program and Surgical Director of the Heart Failure and Heart Transplantation Program.

In addition to that, he is also an Associate Member of the Department of Mechanical Engineering at McGill University and the Principal Investigator at the Research Institute of the MUHC Myocardial Regeneration Laboratory. As one can see, he is going to bring impeccable expertise and experience to the Scientific Advisory Board at Hemostemix. It remains to be seen if the company’s stock a rebound any time soon or not.

Technical Data  

HMTXF stock is trading below the 20-Day and 50-Day Moving averages of $0.22 and $0.22 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.17. The company has a total market capitalization of $11.28 million.